Alzheimer’s Drug Discovery Foundation Funds AgeneBio to Advance Pharmacological Neural Stabilizer Technology

Published August 31, 2010

Alzheimer’s Drug Discovery Foundation Funds AgeneBio to Advance Pharmacological Neural Stabilizer Technology
NEW YORK, Aug. 26 /PRNewswire-USNewswire/ — The Alzheimer’s Drug Discovery Foundation (ADDF) announced today that it has awarded a grant of 0,000 to AgeneBio Inc. to develop a new class of small-molecules that have promise in treating amnestic mild cognitive impairment (aMCI), a neurological condition that often progresses to Alzheimer’s disease and affects more than 3 million aging …
Read more on redOrbit

Narconon Michigan Drug Rehab Celebrates 8 Year Anniversary
Over 600 people completed the Narconon drug rehabilitation program in Michigan.
Read more on PRWeb via Yahoo! News

Beleaguered Cuyahoga County child welfare agency steps up custody filings
The surge of custody cases has occurred as a string of child deaths and system breakdowns raised questions about whether the department is doing enough to protect children at risk.
Read more on The Cleveland Plain Dealer